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Vitamin C deﬁciency globally affects several hundred million people and has been associated with in-
creased morbidity and mortality in numerous studies. In this study, bioavailability of the oxidized form of
vitamin C (L-dehydroascorbic acid or DHA)—commonly found in vitamin C containing food products
prone to oxidation—was studied. Our aimwas to compare tissue accumulation of vitamin C in guinea pigs
receiving different oral doses of either ascorbate or DHA. In all tissues tested (plasma, liver, spleen, lung,
adrenal glands, kidney, muscle, heart, and brain), only sporadic differences in vitamin C accumulation
from ascorbate or DHA were observed except for the lowest dose of DHA (0.25 mg/ml in the drinking
water), where approximately half of the tissues had slightly yet signiﬁcantly less vitamin C accumulation
than from the ascorbate source. As these results contradicted data from rats, we continued to explore the
ability to recycle DHA in blood, liver and intestine in guinea pigs, rats and mice. These investigations
revealed that guinea pigs have similar recycling capacity in red blood cells as observed in humans, while
rats and mice do not have near the same ability to reduce DHA in erythrocytes. In liver and intestinal
homogenates, guinea pigs also showed a signiﬁcantly higher ability to recycle DHA compared to rats and
mice. These data demonstrate that DHA in guinea pigs—as in humans—is almost as effective as ascorbate
as vitamin C source when it comes to taking up and storing vitamin C and further suggest that the guinea
pig is superior to other rodents in modeling human vitamin C homeostasis.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Ascorbate—the reduced form of vitamin C—is a powerful anti-
oxidant and plays an important role as cofactor in many biological
reactions [1]. Suboptimal levels of vitamin C have been associated
with increased morbidity and mortality from conditions such as
cancer and cardiovascular disease in numerous epidemiological
studies [2]. Physiologically, ascorbate is under tight endogenous
regulation ensuring homeostasis in plasma and tissues by a spe-
cialized set of transport proteins and in particular during deﬁ-
ciency, efﬁcient reuptake in the kidneys combined with in-
tracellular recycling by enzymatic systems capable of reducing the
oxidized form of vitamin C (L-dehydroascorbic acid or DHA) back
to ascorbate ensures a minimal loss of the body stores [3,4]. In
recent years, several studies have shown that ascorbate has a
variety of physiological functions as co-factor in enzymaticB.V. This is an open access article u
rythrocyte; ODS, Osteogenicprocesses such as e.g. neurotransmitter synthesis [5] and vasor-
elaxation [6]. A widely used approach to investigate the sig-
niﬁcance of these actions upon health and disease is to use animal
models where suboptimal levels of vitamin C can be achieved by
adjusting the dietary intake. Guinea pigs have been used for this
purpose for decades, but also mice and rats manipulated to be
devoid of the intrinsic ability to synthesize ascorbate are available
[7,8], moreover supplementation to e.g. rats and mice capable of
synthesizing ascorbate has frequently been used. Yet like humans,
guinea pigs have adapted to not being able to synthesize ascorbate
through millions of years of evolution [9], and such absolute de-
pendency on a dietary supply of this vital micronutrient may have
strengthened the preservation mechanisms. It has been reported
that DHA administered to scorbutic Osteogenic Disorder Shionogi
(ODS) rats had only 10% vitamin C activity [10], however this
species—and concurrent strain—has not underwent a comparable
degree of evolutionary adaptation. Our aim with the present ex-
periments was therefore to investigate the bioavailability of vita-
min C forms in guinea pigs and if the recycling capacity of guinea
pigs differs such that DHA—as in humans—will substitute ascor-
bate more effectively in this species.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Stability of drinking solutions and water intake. In A, the stability of as-
corbate and DHA, respectively, are presented over time. The solutions were freshly
made and kept in drinking bottles in the animal facility. Concentrations were
normalized to that of the initial preparation. B shows the daily water intake within
each group. Data is presented as mean7SEM. *¼pr0.05; **¼pr0.01;
***¼pr0.001 by one-way ANOVA with Bonferroni correction for multiple
comparisons.
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2.1. Animals
The experiment was approved by the Danish Animal Experi-
ments Inspectorate. In the bioavailability study, 40 female Hartley
guinea pigs (Charles River Laboratories, Kisslegg, Germany)
weighing 550–600 g upon arrival, were marked with a sub-
cutaneous microchip in the neck, stratiﬁed by weight and rando-
mized into eight groups upon one week after arrival to the animal
facility. All groups were provided with ad libitum access to a
standard guinea pig diet devoid of vitamin C (Ssniff Spezialdiäten
GmbH, Soest, Germany).
2.2. Stability of ascorbate and DHA in solution
Ascorbate and DHA are both known to degrade rapidly in dilute
aqueous solutions [11]. In order to test the stability prior to the
in vivo experiments, all doses of ascorbate (0.1, 0.25, 0.5 and 1 mg/
ml) and DHA (0.25, 0.5 and 1 mg/ml) were made freshly in MQ
water, transferred to drinking bottles, and left in the animal facility
for 24 h with sampling every 12 h. From Fig. 1A, it can be seen that
90% of the originally added amount of DHA was still present after
24 h irrespective of the start concentration. With ascorbate,
however, there was a concentration dependent degradation with
less than 50% of the initial amount still being present after 24 h for
the doses of 0.25 and 0.1 mg/ml. For this reason, it was decided
that animals belonging to these two groups should receive fresh
solutions twice daily.
2.3. Bioavailability study
Animals were group housed in ﬂoor pens in an enriched en-
vironment at 2072 °C with a 12:12 h light–dark cycle, free access
to hay, inspected daily by trained personnel, and weighed twice
weekly. Ascorbate or DHA was supplied in the drinking water for
three weeks as outlined above. Weekly blood sampling took place
by puncture of Vena saphena lateralis [12] and blood was collected
into K3EDTA BD Microtainer tubes [13]. Three weeks after the in-
itiation of the experiment, the guinea pigs were preanaesthetized
with Zoletil mix (Zoletil 50 vets (125 mg Tiletamin and 125 mg
zolazepam; Virbac, Carros, France) dispersed in xylazin (20 mg/ml,
Rompuns, Bayer, Leverkusen, Germany) and butorphanol (10 mg/
ml, Torbugesics, ScanVet Animal Health, Fredensborg, Denmark))
and subsequently anaesthetized by isoﬂuran inhalation (Isoba vet,
MSD Animal Health, Netherlands). Upon absence of reﬂexes (inter-
digital and skin incision) thoracotomy was performed and an in-
tra-cardial blood sample obtained using a syringe with an 18 G,
40 mm needle ﬂushed with 15% K3-EDTA. Immediately after
sampling, the animal was euthanized by decapitation. Tissues
were immediately dissected and frozen on dry ice prior to storage
at 80 °C.
2.4. Recycling study
In a subsequent experiment, four male Hartley guinea pigs (5
weeks old, 400 g bodyweight) (Charles River Laboratories, Kis-
slegg, Germany), four male Spraque Dawley rats (7 weeks old,
200 g bodyweight (Taconic, Ejby, Denmark)) and four male black6
(B6NTac) mice (7 weeks old, 23 g bodyweight (Taconic, Ejby,
Denmark)) were euthanized as described above following one
week of equilibration and blood, liver and intestinal samples
(sectioned from the middle third of the jejunum) were obtained.
Blood samples were immediately centrifuged (5 min at 2000 g,
4 °C) and erythrocytes (RBCs) were isolated and washed three
times in 10 volumes of PBS. Subsequently, RBCs were diluted to25% with PBS and used in the recycling experiments are described
below. Tissues were gently rinsed and blotted dry and subse-
quently homogenized in nine volumes of PBS and used directly in
recycling experiments as outlined below.
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H. Frikke-Schmidt et al. / Redox Biology 7 (2016) 8–13102.5. Vitamin C measurements
Blood samples were immediately centrifuged for 2 min at
16,000 g (4 °C) and stabilized with ice cold 10% (w/v) MPA
containing 2 mmol/L Na2-EDTA as reported previously [14] and
stored at 80 °C until analysis. Tissue samples (approximately
50 mg) were taken from 80 °C and homogenized in cold (4 °C)
PBS and centrifuged (15.000 g, for 1 min at 4 °C) before stabili-
zation with MPA. The stability of ascorbate and DHA in MPA sta-
bilized plasma has been studied previously and found adequate in
preserving the in vivo equilibrium [15]. Ascorbate and total vita-
min C (ascorbateþDHA; obtained by reduction with tris[2-car-
boxyethyl]phosphinehydrochloride as described in [16]) were
quantiﬁed by high-performance liquid chromatography with
coulometric determination and the DHA concentrations were
subsequently assessed by subtraction of ascorbate from total vi-
tamin C using uric acid as endogenous internal standard [15].
2.6. Ascorbate recycling measurements
Recycling capacity of DHA to ascorbate in RBCs was essentially
assessed as described previously [17]. In brief, RBCs (6.25% he-
matocrit) were preconditioned for 20 min at 37 °C under gentle
rocking, after which they were incubated for 20 min in the pre-
sence of 100 mM DHA. Aliquots were taken at t¼0 and 20 min and
analyzed for ascorbate as described above. For intestinal and liver
tissue, 250 ml tissue homogenate was diluted with 710 ml PBS and
preincubated for 20 min at 37 °C, after which 40 ml 2.5 mM DHA
was added for a ﬁnal concentration of 100 mM. Following a 20 min
incubation period, the accumulated ascorbate was measured.
2.7. Statistics
In the water stability experiment, one-sided t-tests were used
to compare the observed level to the initial 100%. To compensate
for multiple comparisons, a Bonferroni factor of 4 for the ascorbate
solutions and 3 for the DHA solutions was applied to the p-values
(Fig. 1). Body and organ weights (Table 1) and the relative oral
bioavailability of ascorbate and DHA in tissues (Table 2) were
analyzed by one-way ANOVA using Bonferroni correction for
multiple comparisons. The data obtained in the recycling experi-
ments were not normally distributed (Fig. 3). Thus, data were
compared by Kruskal–Wallis multiple comparison test for non-
parametric data. Finally, ascorbate concentrations between species
were analyzed by two-way ANOVA using tissue and species as
factors (Table 3). A p-value less than 0.05 was considered statis-
tically signiﬁcant.Ta
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s.3. Results
3.1. Water intake
The average daily water intake within each group can be seen
in Fig. 1B. The guinea pigs on vitamin C deﬁcient diet drank
slightly but signiﬁcantly more water than the groups receiving
ascorbate or DHA supplementation. There was no difference in the
water intake between the dosage groups.
3.2. Body and tissue weights
The guinea pigs were randomized and stratiﬁed for weight at
the beginning of the study and the bodyweight was monitored
twice weekly. As can be seen in Table 1, there was no difference
between groups neither at start nor at euthanization. Yet the
weight of the depleted guinea pigs (0 mg/ml group) started to
Table 2
Statistics for Fig. 2.
Statistical analysis Test parameters Water
supplement
Plasma Liver Spleen Lung Adrenal
glands
Kidney Muscle Heart Cerebellum Cortex
One way ANOVA Difference between doses
on tissue total vitamin C
tissue levels
Ascorbate *** *** *** *** *** *** n.s. *** ** **
DHA *** *** n.s. * *** *** *** *** n.s. n.s.
Difference between doses
on tissue ASCORBATE
levels
Ascorbate *** *** *** ** *** *** n.s. *** ** **
DHA ** *** * n.s. *** *** ** *** n.s. n.s.
Difference between doses
on tissue DHA levels
Ascorbate n.s. n.s. n.s. * n.s. n.s. n.s. *** n.s. n.s.
DHA n.s. n.s. n.s. * n.s. n.s. *** *** ** n.s.
Selected Bonferroni compar-
isons following one way
ANOVA
ascorbate versus DHA dose
upon total vitamin C tissue
levels
1 mg/ml n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s.
0.5 mg/ml *** n.s. n.s. n.s. n.s. * n.s. n.s. n.s. n.s.
0.25 mg/ml n.s. ** n.s. ** n.s. *** n.s. *** n.s. n.s.
ascorbate versus DHA dose
upon ascorbate tissue
levels
1 mg/ml n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s.
0.5 mg/ml *** n.s. n.s. n.s. n.s. * n.s. n.s. n.s. n.s.
0,25 mg/ml n.s. ** n.s. n.s. n.s. *** n.s. n.s. n.s. n.s.
ascorbate versus DHA dose
upon DHA tissue levels
1 mg/ml n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s.
0.5 mg/ml n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s.
0.25 mg/ml n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s.
The data of Fig. 2 was analyzed by one-way ANOVA using dose as factor and subsequently for the comparison of ascorbate to DHA accumulation using Bonferroni correction
for multiple comparisons. For both types of tests *¼pr0.05; **¼pr0.01; and ***¼pr0.001, whereas n.s.¼non signiﬁcant.
Table 3
Vitamin C concentrations in liver and intestine from guinea pig, rat and mouse. No
statistically signiﬁcant differences were observed by two-way ANOVA using tissue
and species as factors.
Guinea pig Rat Mouse
Liver Ascorbate (nmol/g tissue) 10317281 8447280 7077197
Intestinal Ascorbate (nmol/g tissue) 6297105 7007178 8577183
H. Frikke-Schmidt et al. / Redox Biology 7 (2016) 8–13 11stagnate a few days prior to euthanization (data not shown). The
weights of the organs, given in Table 1, were not affected by the
different doses except for the spleens in the depleted group, which
were signiﬁcantly enlarged.
3.3. Tissue vitamin C levels
In the tissues shown in Fig. 2 (plasma, liver, spleen, kidney,
adrenal glands, cortex and cerebellum from the brain, lung, heart,
and skeletal muscle), vitamin C levels were evaluated as ascorbate
alone, DHA alone, and as total vitamin C levels (ascorbateþDHA),
respectively. Statistics from these data are given in Table 2. In all
tissues, we found a signiﬁcant effect of dose on one or more of theFig. 2. Tissue vitamin C levels. Vitamin C levels in plasma (A), liver (B), spleen (C), kidne
muscle (J). Vitamin C levels are depicted as ascorbate (gray bar part), oxidized vitamin C
Statistics are present in Table 2. Data is presented as mean7SEM.measures of vitamin C content with both ascorbate and DHA
supplementation reﬂecting that a dose response relationship was
present. In half of the tissues investigated, we found no signiﬁcant
difference between ascorbate and DHA dosing when given in
equivalent concentrations, whereas there were signiﬁcant differ-
ences with only the lower doses in plasma, liver, lung, kidney and
heart. This reﬂects that DHA is almost as effective as ascorbate
when it comes to provide vitamin C accumulation within tissues.
From Fig. 2, it is also apparent that lungs, heart, and muscle con-
tain more vitamin C in the form of DHA than the remaining tis-
sues. Regarding the plasma levels of vitamin C there was no dif-
ference in ascorbate, DHA or total vitamin C levels, respectively,
between any of the groups at the start of the experiment (one way
ANOVA, data not shown) and the levels of vitamin C adjusted
within the ﬁrst week after which they remained relatively con-
stant (data not shown).
3.4. Recycling capacity in RBC, liver and intestine
The recycling capacity was assessed in RBCs, liver, and intestine
in guinea pigs, rats, and mice as described above. The results are
shown in Fig. 3. Signiﬁcant effects of species was observed for bothy (D), adrenal glands (E), cortex (F), cerebellum (G), lung (H), heart (I), and skeletal
(DHA) (white bar part), and total vitamin C (total bar height). N.D.¼Not depicted.
Fig. 3. Recycling capacity in liver, intestine and erythrocytes of guinea pig, rat and
mouse. Liver or intestinal homogenate or isolated erythrocytes were incubated
with 100 mmol/L dehydroascorbic acid for 20 min and the accumulation of ascor-
bate was expressed as % of initial concentration. Erythrocytes from rats and mice
did not contain any initial ascorbate, nor did they accumulate any following in-
cubation. Data were compared by Kruskal–Wallis multiple comparison test for non-
parametric data.
H. Frikke-Schmidt et al. / Redox Biology 7 (2016) 8–1312RBC, liver, and intestinal recycling capacity (po0.05 or less). Only
guinea pigs were able to recycle DHA to ascorbate in RBCs
(po0.01). For liver and intestinal tissue, the rats and mice were
unable to maintain their vitamin C pool reduced as indicated by
the fact that the ascorbate concentration dropped during the
20 min incubation period. In guinea pigs, the vitamin C pool was
intact after 20 min suggesting an ability to balance in situ oxida-
tion and recycling. Initial levels of tissue ascorbate are found in
Table 3. Washed RBCs did not contain ascorbate and no statisti-
cally signiﬁcant differences were observed by two-way ANOVA
using tissue and species as factors.4. Discussion
The present study demonstrates that DHA constitutes an
equally good vitamin C source as its reduced form ascorbate in
guinea pigs. Moreover, our data suggest that the guinea pig is
superior to mouse and rat and more similar to humans when it
comes to the ability to recycle vitamin C.
The presence of DHA in foods containing vitamin C due to
oxidation has been widely acknowledged and several decades ago,
it was found that DHA could indeed substitute vitamin C in hu-
mans [18–20]; ﬁndings that have been repeated in recent years as
well [21]. Even though the uptake mechanisms differ with ascor-
bate being actively taken up by the sodium dependent vitamin C
transporters (SVCTs) and DHA utilizing facilitated diffusion into
cells through the glucose transporters (GLUT), the ability of cells to
almost instantly reduce DHA back to ascorbate suggests that DHA
would indeed be expected to be as effective as ascorbate [22]. To
the best of our knowledge only very few studies exist that directly
compare DHA to ascorbate administration in animal models
whereof the majority is several decades old [10,23–29]. In general,
it is reported that DHA is as effective as ascorbate in raising vita-
min C levels, yet there are a few exceptions: Ogiri et al. showed
that DHA can only account for 10% of vitamin C activity in the OSD
rat [10], and Hornig et al. found that isotope labeled DHA appeared
slower and to a smaller extent in several tissues upon IV injection
in guinea pigs. There seems to be a common consensus that the
conversion of administered DHA to ascorbate depends on the
route of administration with differences in appearance and dis-
tribution pattern when using oral ingestion, IP, and IV, respectively
[26–28]. However, we consider oral ingestion as the most relevant
route of administration when comparing ascorbate and DHA as
this mimics uptake in humans, and we hypothesized that theconﬂicting results obtained by Ogiri et al. [10] may rather relate to
the rat being less efﬁcient in recycling DHA compared to species
like humans and guinea pigs that lost the ability to synthesize
vitamin C millions of years ago and where a compensatory in-
crease in recycling capacity would be likely to have evolved. One
example could be the RBCs, where guinea pigs in this study
showed a recycling capacity comparable to that of humans, while
rats and mice did not have a signiﬁcant capacity to recycle DHA.
We have previously shown that the RBCs of guinea pigs have the
capacity to recycle the entire vitamin C pool of the blood once
approximately every three minutes and similar data have been
found in humans suggesting that in these species, RBCs constitute
a substantial antioxidant reserve in vivo [30,31].
When investigating the potential impact of vitamin C supple-
mentation and vitamin C deﬁciency in relation to human disease
development, we recommend that great care should be taken in
choosing the right animal model. Transgenic technology in mice and
rats certainly allows for mechanistic elucidations that would other-
wise be hard to obtain (e.g. [8]), yet it might have signiﬁcant impact
on the results when a species with less capacity for recycling vitamin
C is used to extrapolate to the human situation. However, a limitation
of our study is that we have not assessed if the variety of transgenic
rats and mice used in vitamin C research have in fact the same re-
cycling capacity as their respective wild types.
Finally, when comparing the different tissues, it immediately
becomes apparent from Fig. 2 that the brain is far more effective in
retaining vitamin C as it ﬁrstly does not become depleted in the
unsupplemented group and, secondly, that the tissue concentra-
tion remains relatively constant even with 10 times lower doses
(1 mg/ml versus 0.1 mg/ml). The capacity of the brain to hold on to
vitamin C is widely acknowledged [32–34] and our conﬁrmatory
ﬁnding supports the physiological relevance of the data. Moreover,
we recently reported that saturation of the brain occurs faster than
for most other tissues [35]. It can also be extracted from Fig. 2 that
lung, muscle, and heart are less efﬁcient in keeping the DHA/total
vitamin C ratio low presumably due to a higher turnover driven by
the high oxygen tension of these tissues.
In conclusion, we ﬁnd that DHA can substitute ascorbate as
vitamin C source with respect to tissue uptake and storage in
guinea pigs as in humans and that they appear to have similar
capacity to recycle vitamin C as opposed to mice and rats. This may
render the guinea pig as a more appropriate animal model when
studying in vivo effects of vitamin C recycling.Conﬂicts of interest
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